0

Journal Articles

in Psychopharmacology
 1-14 of 14 Articles
Original Investigation |  April 29, 2013 ONLINE FIRST
Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery
Andrew D. Auerbach, MD, MPH; Eric Vittinghoff, PhD; Judith Maselli, MSPH; et al.
JAMA Intern Med. 2013;():1-7. doi:10.1001/jamainternmed.2013.714.
INCLUDES: , Supplemental Content
Invited Commentary |  April 29, 2013 ONLINE FIRST
Selective Serotonin Reuptake Inhibitors and Surgery: To Hold or Not to Hold, That Is the Question:  Comment on “Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery”
Marko Mrkobrada, MD, FRCPC; Daniel G. Hackam, MD, PhD, FRCPC
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.718.
Review Article |  April 08, 2013
Pharmacologic Therapy for Primary Restless Legs Syndrome:  A Systematic Review and Meta-analysis
Timothy J. Wilt, MD, MPH; Roderick MacDonald, MS; Jeannine Ouellette; et al.
JAMA Intern Med. 2013;173(7):496-505. doi:10.1001/jamainternmed.2013.3733.
INCLUDES: , Supplemental Content
Research Letters |  December 10, 2012
Management of Substance Use Disorders in Ambulatory Care in the United States, 2001-2009
Joseph W. Frank, MD; John Z. Ayanian, MD, MPP; Jeffrey A. Linder, MD, MPH
Arch Intern Med. 2012;172(22):1759-1760. doi:10.1001/archinternmed.2012.4504.
Editor's Correspondence |  October 22, 2012
Generic Competition in a Flawed System: Pill Them, Bill Them
Alain Braillon, MD, PhD
Arch Intern Med. 2012;172(19):1522-1523. doi:10.1001/archinternmed.2012.4389.
Research Letters |  August 13, 2012
Prescription Drug Abuse and DEA-Sanctioned Drug Take-Back Events: Characteristics and Outcomes in Rural Appalachia
Jeffrey A. Gray, PharmD; Nicholas E. Hagemeier, PharmD, PhD
Arch Intern Med. 2012;172(15):1186-1187. doi:10.1001/archinternmed.2012.2374.
Perspectives |  August 13, 2012 FREE
Pain as a Cause of Agitated Delirium
Diane E. Meier, MD
Arch Intern Med. 2012;172(15):1130. doi:10.1001/archinternmed.2012.2088.
Invited Commentary |  August 13, 2012
When It's the Right Care, More Is Better:  Comment on “Palliative Care and Quality of Life” and “Pain as a Cause of Agitated Delirium”
Steven Z. Pantilat, MD, FAAHPM, SFHM
Arch Intern Med. 2012;172(15):1172-1173. doi:10.1001/archinternmed.2012.2894.
Editor's Correspondence |  August 13, 2012
Do Angiotensin Receptor Blockers Really Hold Promise for the Improvement of Cognitive Functioning?
Chittaranjan Andrade, MD; Praveen Fernandes, MD
Arch Intern Med. 2012;172(15):1191-1192. doi:10.1001/archinternmed.2012.2091.
Editor's Correspondence |  August 13, 2012
Do Angiotensin Receptor Blockers Really Hold Promise for the Improvement of Cognitive Functioning?—Reply
Ihab Hajjar, MD, MS; Wendy Mack, PhD, MS; Lewis Lipsitz, MD
Arch Intern Med. 2012;172(15):1191-1192. doi:10.1001/archinternmed.2012.3885.
Editor's Correspondence |  November 24, 2008
Limitations of the Anticholinergic Risk Scale
Arch Intern Med. 2008;168(21):2386. doi:10.1001/archinte.168.21.2386-a.
Original Investigation |  March 13, 2006 FREE
Physician Alerts to Increase Antidepressant Adherence:  Fax or Fiction?
Kara Zivin Bambauer, PhD; Alyce S. Adams, PhD; Fang Zhang, PhD; et al.
Arch Intern Med. 2006;166(5):498-504. doi:10.1001/archinte.166.5.498.
Original Investigation |  September 27, 2004 FREE
Cognitive Behavior Therapy and Pharmacotherapy for Insomnia:  A Randomized Controlled Trial and Direct Comparison
Gregg D. Jacobs, PhD; Edward F. Pace-Schott, MA; Robert Stickgold, PhD; et al.
Arch Intern Med. 2004;164(17):1888-1896. doi:10.1001/archinte.164.17.1888.
Original Investigation |  April 12, 1999 FREE
Physical Symptoms Distress Index:  A Sensitive Tool to Evaluate the Impact of Pharmacological Agents on Quality of Life
Richard B. Anderson, EdD; Norman K. Hollenberg, MD, PhD; Gordon H. Williams, MD
Arch Intern Med. 1999;159(7):693-700. doi:10.1001/archinte.159.7.693.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Psychiatry
Original Article  |  March 27, 2013
Effects of Varenicline and Bupropion Sustained-Release Use Plus Intensive Smoking Cessation Counseling on Prolonged Abstinence From Smoking and on Depression, Negative Affect, and Other Symptoms of Nicotine Withdrawal
Paul M. Cinciripini, PhD; Jason D. Robinson, PhD; Maher Karam-Hage, MD; et al.
JAMA
Original Contribution  |  April 03, 2013
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy:  A Randomized Clinical Trial
Ellen M. Lavoie Smith, PhD; Herbert Pang, PhD; Constance Cirrincione, MS; et al.
JAMA Psychiatry
Original Article  |  February 6, 2013
The Sertraline vs Electrical Current Therapy for Treating Depression Clinical Study:  Results From a Factorial, Randomized, Controlled Trial
Andre R. Brunoni, MD, PhD; Leandro Valiengo, MD; Alessandra Baccaro, BA; et al.
JAMA Psychiatry
Original Article  |  February 6, 2013
Antidepressants Normalize the Default Mode Network in Patients With Dysthymia
Jonathan Posner, MD; David J. Hellerstein, MD; Inbal Gat, BA; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems